The Trump administration is ending a Medicare drug subsidy program. Here’s how it could affect costs

The Trump administration is ending a Medicare drug subsidy program initiated by the Biden administration in 2024, leading to potential 2027 premium increases for 25 million Medicare Part D beneficiaries. Federal officials claim the impact will be minimal, with most seeing less than a $10-per-month increase, while Democrats criticize the move as increasing healthcare costs for seniors.